I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Camilla Zecchetto
55
results:
Format
Online (55)
Mediatypes
Articles (Online) (21)
OpenAccess-fulltext (34)
Sorted by: Relevance
Sorted by: Year
?
1
Integration of liposomal irinotecan in the first-line treat..:
Melisi, Davide
;
Casalino, Simona
;
Pietrobono, Silvia
...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024
Link:
https://doi.org/10.1177/..
?
2
Multicenter phase I/II trial of gemcitabine, oxaliplatin an..:
Pressiani, Tiziana
;
Balsano, Rita
;
Giordano, Laura
...
European Journal of Cancer. 207 (2024) - p. 114196 , 2024
Link:
https://doi.org/10.1016/..
?
3
Perioperative NALIRIFOX in patients with resectable pancrea..:
Melisi, Davide
;
Zecchetto, Camilla
;
Merz, Valeria
...
European Journal of Cancer. 196 (2024) - p. 113430 , 2024
Link:
https://doi.org/10.1016/..
?
4
YAP Activation Is Associated with a Worse Prognosis of Poor..:
Bencivenga, Maria
;
Torroni, Lorena
;
Dal Cero, Mariagiulia
...
Journal of Personalized Medicine. 13 (2023) 9 - p. 1294 , 2023
Link:
https://doi.org/10.3390/..
?
5
Current Role and Future Perspectives of Immunotherapy and C..:
Conci, Simone
;
Catalano, Giovanni
;
Roman, Diletta
...
International Journal of Medical Sciences. 20 (2023) 7 - p. 858-869 , 2023
Link:
https://doi.org/10.7150/..
?
6
The role of nanoliposomal irinotecan plus fluorouracil/leuc..:
Procaccio, Letizia
;
Merz, Valeria
;
Fasano, Morena
...
Cancer Medicine. 12 (2023) 13 - p. 14337-14345 , 2023
Link:
https://doi.org/10.1002/..
?
7
Targeting FGFR Pathway Is Not an Effective Therapeutic Stra..:
Zecchetto, Camilla
;
Quinzii, Alberto
;
Casalino, Simona
...
Journal of Personalized Medicine. 13 (2023) 3 - p. 508 , 2023
Link:
https://doi.org/10.3390/..
?
8
Autotaxin Secretion Is a Stromal Mechanism of Adaptive Resi..:
Pietrobono, Silvia
;
Sabbadini, Fabio
;
Bertolini, Monica
...
Cancer Research. 84 (2023) 1 - p. 118-132 , 2023
Link:
https://doi.org/10.1158/..
?
9
Predictive Biomarkers for a Personalized Approach in Resect..:
Merz, Valeria
;
Mangiameli, Domenico
;
Zecchetto, Camilla
...
Frontiers in Surgery. 9 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
10
Clinical Response to Futibatinib in Patients with High-Leve..:
Quinzii, Alberto
;
Zecchetto, Camilla
;
Casalino, Simona
...
Clinical Drug Investigation. 42 (2022) 8 - p. 697-701 , 2022
Link:
https://doi.org/10.1007/..
?
11
Targeting KRAS: The Elephant in the Room of Epithelial Canc..:
Merz, Valeria
;
Gaule, Marina
;
Zecchetto, Camilla
...
Frontiers in Oncology. 11 (2021) - p. , 2021
Link:
https://doi.org/10.3389/..
?
12
Safety and activity of the TGFβ receptor I kinase inhibitor..:
Melisi, Davide
;
Oh, Do-Youn
;
Hollebecque, Antoine
...
Journal for ImmunoTherapy of Cancer. 9 (2021) 3 - p. e002068 , 2021
Link:
https://doi.org/10.1136/..
?
13
Role of next-generation genomic sequencing in targeted agen..:
Melisi, Davide
;
Cavaliere, Alessandro
;
Gobbo, Stefano
...
Pancreatology. 21 (2021) 6 - p. 1038-1047 , 2021
Link:
https://doi.org/10.1016/..
?
14
A phase II trial of the FGFR inhibitor pemigatinib in patie..:
Merz, Valeria
;
Zecchetto, Camilla
;
Simionato, Francesca
...
Therapeutic Advances in Medical Oncology. 12 (2020) - p. 175883592093788 , 2020
Link:
https://doi.org/10.1177/..
?
15
Organisational challenges, volumes of oncological activity ..:
Zuliani, Serena
;
Zampiva, Ilaria
;
Tregnago, Daniela
...
European Journal of Cancer. 135 (2020) - p. 159-169 , 2020
Link:
https://doi.org/10.1016/..
1-15